[go: up one dir, main page]

AR026797A1 - PHARMACEUTICAL COMPOUND WITH A PERMEATION PROMOTING ADDITIVE FOR THE TRANSDERMAL HORMONE ADMINISTRATION. - Google Patents

PHARMACEUTICAL COMPOUND WITH A PERMEATION PROMOTING ADDITIVE FOR THE TRANSDERMAL HORMONE ADMINISTRATION.

Info

Publication number
AR026797A1
AR026797A1 ARP010100041A ARP010100041A AR026797A1 AR 026797 A1 AR026797 A1 AR 026797A1 AR P010100041 A ARP010100041 A AR P010100041A AR P010100041 A ARP010100041 A AR P010100041A AR 026797 A1 AR026797 A1 AR 026797A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compound
promoting additive
permeation promoting
hormone administration
transdermal hormone
Prior art date
Application number
ARP010100041A
Other languages
Spanish (es)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR026797A1 publication Critical patent/AR026797A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto farmacéutico para la administracion transdermal de una o varias hormonas, por fijacion adhesiva de contacto sobre la piel, con al menos unacapa matriz que contiene hormonas que contiene al menos un aditivo promotor de la permeacion cutá nea, caracterizado por presentar el mencionado aditivo unaestructura básica 1,4-dioxano-2,5-diona de formula genérica en donde los radicales R1 y R2 son grupos hidrocarburo o grupos hidrocarburo sustituidos o gruposfuncionales.A pharmaceutical compound for the transdermal administration of one or more hormones, by adhesive contact fixation on the skin, with at least one matrix layer containing hormones containing at least one cutaneous permeability promoting additive, characterized by presenting said additive a structure basic 1,4-dioxane-2,5-dione of generic formula wherein the radicals R1 and R2 are hydrocarbon groups or substituted hydrocarbon groups or functional groups.

ARP010100041A 2000-01-07 2001-01-05 PHARMACEUTICAL COMPOUND WITH A PERMEATION PROMOTING ADDITIVE FOR THE TRANSDERMAL HORMONE ADMINISTRATION. AR026797A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2000100333 DE10000333A1 (en) 2000-01-07 2000-01-07 Pharmaceutical composition for the transdermal administration of hormones with a permeation-improving additive

Publications (1)

Publication Number Publication Date
AR026797A1 true AR026797A1 (en) 2003-02-26

Family

ID=7626866

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100041A AR026797A1 (en) 2000-01-07 2001-01-05 PHARMACEUTICAL COMPOUND WITH A PERMEATION PROMOTING ADDITIVE FOR THE TRANSDERMAL HORMONE ADMINISTRATION.

Country Status (4)

Country Link
AR (1) AR026797A1 (en)
AU (1) AU2369801A (en)
DE (1) DE10000333A1 (en)
WO (1) WO2001049273A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873371B1 (en) * 2004-07-26 2008-07-04 Sod Conseils Rech Applic NEW METHOD OF SYNTHESIS OF 2,5 DIOXANE 1,4 DIONES
DE102006050558B4 (en) 2006-10-26 2009-03-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing norelgestromin for contraception and hormone replacement
DE102010004769A1 (en) 2009-07-08 2011-01-13 Kuchenbecker, Manfred, Dr.-Ing. Reluctance generator for feed in alternating or three-phase current constant voltage and constant frequency at variable speed, is provided with multiple uniform oppositely displaced partial phases for phase of output voltage
ES2702723T3 (en) 2012-02-09 2019-03-05 Novus Int Inc Heteroatoms containing cyclic dimers
MX2015000395A (en) 2012-07-12 2015-04-10 Novus Int Inc Matrix and layer compositions for protection of bioactives.
BR112016002609A2 (en) 2013-08-09 2017-08-01 Chemours Co Fc Llc skin care composition and method for making a composition
US10584306B2 (en) 2017-08-11 2020-03-10 Board Of Regents Of The University Of Oklahoma Surfactant microemulsions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002079B (en) * 1994-07-26 1995-12-05 Lavipharm A E System of a special structure and composition for the rapid transdermal administration of oestrogens.
WO1996040087A2 (en) * 1995-06-07 1996-12-19 Cygnus, Inc. Pressure sensitive acrylate adhesive composition cross-linked with aluminum acetylacetonate and containing a drug having a reactive aromatic hydroxyl group

Also Published As

Publication number Publication date
WO2001049273A2 (en) 2001-07-12
DE10000333A1 (en) 2001-07-19
AU2369801A (en) 2001-07-16
WO2001049273A3 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
PA8468401A1 (en) COMPOUNDS FOR THE TREATMENT OF ISCHEMIA
ATE229322T1 (en) PHARMACEUTICAL CARRIER SUITABLE FOR APPLICATION OF PHARMACEUTICAL COMPOUNDS TO MUCOSAL SURFACES
DK1079813T3 (en) Pharmaceutical carrier device suitable for administering pharmaceutical compounds to mucosal surfaces
AR009516A1 (en) A PRESSURE SENSITIVE ADHESIVE MATRIX PATCH DEVICE, A METHOD FOR PREPARING SUCH A DEVICE AND A METHOD FOR USING SUCH DEVICE IN THE TRANSDERMIC SUPPLY OF A DRUG.
AR027060A1 (en) MANNICH BASES OF 1-NAFTOL AND 2-NAFTOL SUBSTITUTED, PROCEDURE FOR PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS, AS WELL AS THE USE OF THESE COMPOUNDS FOR THE MANUFACTURE OF MEDICINES
AR033808A1 (en) A TOPICAL COMPOSITION OF LOCAL ANESTHESIA AND THE PATCHES AND CONTAINERS CONTAINING IT
UY26496A1 (en) PHARMACEUTICAL COMPOSITIONS PROVIDING POTENTIAL DRUG CONCENTRATIONS
ES2161697T3 (en) PEPTIDES AGONISTAS AMILINA AND USES OF THE SAME.
SV1995000045A (en) BENZOXAZOLIL- AND BENZOTIAZOLILOXAZOLIDINONAS, REF. LE A 30616-SV
UY26689A1 (en) HYDANTOINE CONTAINING GLUCOCINASE ACTIVATORS
ES2096439T3 (en) COMPOSITE NON-WOVEN MATERIAL AND ITS APPLICATION TO ANY ABSORBENT HYGIENE ITEM.
ATE305775T1 (en) PERCUTANE ABSORPTION PREPARATION CONTAINING TULOBUTEROL
AR050621A1 (en) TRANSDERMAL THERAPEUTIC SYSTEM WITH AN ADHERENT COAT PROCEDURE FOR SILICONING A BACK COAT AND EMPLOYMENT OF THE BACK COAT
AR026797A1 (en) PHARMACEUTICAL COMPOUND WITH A PERMEATION PROMOTING ADDITIVE FOR THE TRANSDERMAL HORMONE ADMINISTRATION.
AR026338A1 (en) POLYCYCLIC DIHYDROTIAZOLS, PROVIDED IN POSITION 2 OF SUBSTITUTED RENTAL RADICALS, PROCEDURE FOR THE PREPARATION AND USE OF COMMON MEDICATIONS
ECSP034531A (en) SUBSTITUTED DERIVATIVES OF C-CICLOHEXILMETILAMINA
AR018162A1 (en) SUBSTITUTED PIRROLS, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION
AR030662A1 (en) BETA-TIO-ALFA-AMINO ACIDS, PROCEDURE FOR MANUFACTURING, MEDICINES CONTAINING THESE COMPOUNDS AND THE USE OF THIOAMINO ACIDS FOR THE PREPARATION OF MEDICINES
CO4940430A1 (en) POLYCLIC COMPOUNDS CONTAINING HYDROGENATED STAUROSPORIN WITH CONVENIENT PHARMACOLOGICAL PROPERTIES AND AN INHIBITING EFFECT ON THE GROWTH OF TUMOR CELLS
ES2196069T3 (en) MORFINOID DERIVATIVES CONDENSED WITH HETEROCICLES.
ES2162641T3 (en) PREPARED IN THE FORM OF PATCHES FOR THE TREATMENT OF PLANTS.
AR025391A1 (en) PROCEDURE FOR APPLYING A PREPARATION IN A LIQUID PHASE THAT CONTAINS AN ACTIVE PRINCIPLE ON A FLAT SUBSTRATE
ES2173453T3 (en) NEW DEVICES FOR THE TRANSDERMAL ADMINISTRATION OF TRIMEGESTONA.
BRPI0011135B8 (en) transdermal therapeutic delivery system containing neuroleptic agent
ES2188021T3 (en) METHOD TO AVOID THE UNFAULT USE OF A PERCUTANEOUS THERAPEUTIC SYSTEM.

Legal Events

Date Code Title Description
FB Suspension of granting procedure